Pages with the most revisions

Showing below up to 50 results starting with #1.

View (previous 50) (next 50) (20 | 50 | 100 | 250 | 500)

1. Immunoassays for free light chain measurement ‎(218 revisions)
2. AL Amyloidosis ‎(191 revisions)
3. Monitoring IIMM patients using sFLCs ‎(185 revisions)
4. Analysis of Ig heavy chain/light chain pairs (Hevylite™) ‎(168 revisions)
5. Serum versus urine tests for free light chains ‎(154 revisions)
6. The kidney and monoclonal free light chains ‎(150 revisions)
7. Other malignancies with monoclonal FLCs ‎(139 revisions)
8. Sensitivity of serum free light chain assays ‎(138 revisions)
9. Screening studies using serum free light chain analysis ‎(126 revisions)
10. Immune stimulation and elevated polyclonal free light chains ‎(125 revisions)
11. Monoclonal gammopathies of undetermined significance (MGUS) ‎(114 revisions)
12. Light chain multiple myeloma (LCMM) ‎(101 revisions)
13. Biology of immunoglobulin light chains ‎(100 revisions)
14. Renal diseases and free light chains ‎(96 revisions)
15. Serum free light chain publications ‎(87 revisions)
16. Quality assurance for serum free light chain analysis ‎(80 revisions)
17. Dr Bence Jones and the history of free light chains ‎(78 revisions)
18. Intact immunoglobulin multiple myeloma (IIMM) - theoretical considerations of sFLC and Ig measurements ‎(78 revisions)
19. Intact immunoglobulin MM (IIMM) - sFLCs at diagnosis ‎(76 revisions)
20. SECTION 2 - Free light chains and monoclonal gammopathies ‎(75 revisions)
21. Nonsecretory multiple myeloma (NSMM) ‎(72 revisions)
22. Overview - The clinical importance of serum free light chain analysis ‎(72 revisions)
23. Localised amyloid disease ‎(65 revisions)
24. Asymptomatic (smouldering) multiple myeloma (ASMM) ‎(63 revisions)
25. Section 1 ‎(61 revisions)
26. Implementation and interpretation of free light chain assays ‎(54 revisions)
27. Light chain deposition disease (LCDD) ‎(44 revisions)
28. Normal ranges and reference intervals ‎(43 revisions)
29. Contents ‎(42 revisions)
30. Hevylite publications ‎(35 revisions)
31. Section 2 ‎(31 revisions)
32. Introduction ‎(27 revisions)
33. Instrumentation for free light chain immunoassays ‎(26 revisions)
34. Classification of diseases with increased immunoglobulins ‎(25 revisions)
35. Main Page ‎(24 revisions)
36. Questions and answers about FLCs ‎(24 revisions)
37. APR-2012Contents ‎(23 revisions)
38. Multiple myeloma - Introduction ‎(21 revisions)
39. Preface and Abbreviations ‎(19 revisions)
40. Guidelines for use of serum free light chain assays ‎(18 revisions)
41. Abbreviations ‎(18 revisions)
42. Apr-2012Nonsecretory multiple myeloma (NSMM) ‎(13 revisions)
43. Section 6 ‎(13 revisions)
44. 2011-April-Guidelines for use of serum free light chain assays ‎(13 revisions)
45. Apr2012Contents ‎(11 revisions)
46. Cerebrospinal fluid and free light chains ‎(10 revisions)
47. Data:left ‎(9 revisions)
48. New Things ‎(9 revisions)
49. SECTION 1 - Immunoglobulin free light chains and their analysis ‎(8 revisions)
50. Test ‎(8 revisions)

View (previous 50) (next 50) (20 | 50 | 100 | 250 | 500)